These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1819701)

  • 1. Quantitation by radioimmunoassay of PAF in human saliva.
    Cooney SJ; Smal MA; Baldo BA
    Lipids; 1991 Dec; 26(12):1140-3. PubMed ID: 1819701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of platelet activating factor (PAF) in human saliva. Quantitation by radioimmunoassay.
    Cooney SJ; Smal MA; Baldo BA
    Clin Chim Acta; 1991 Aug; 200(2-3):161-73. PubMed ID: 1777966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor(s) of platelet-activating factor (PAF) in human saliva.
    Smal MA; Baldo BA
    Lipids; 1991 Dec; 26(12):1144-7. PubMed ID: 1819702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The measurement of PAF (platelet activating factor) in human saliva: standardization of the method].
    Staffolani N; Gefrra M; Ribaldi E; Palazzo L; Gresele P; Goracci G
    Minerva Stomatol; 1996 Mar; 45(3):69-73. PubMed ID: 8926976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for platelet-activating factor.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1126-9. PubMed ID: 1819698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
    Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Uemura Y; Ou M; Iwamoto N; Mori T
    Life Sci; 1994; 54(6):429-37. PubMed ID: 8295490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive and specific radioimmunoassay for platelet-activating factor.
    Wang C; Tai HH
    Lipids; 1992 Mar; 27(3):206-8. PubMed ID: 1522765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF levels in saliva are regulated by inflammatory cells.
    Ribaldi E; Guerra M; Mezzasoma AM; Staffolani N; Goracci G; Gresele P
    J Periodontal Res; 1998 May; 33(4):237-41. PubMed ID: 9689619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific, sensitive and high-capacity immunoassay for PAF.
    Baldo BA; Smal MA; McCaskill AC
    Lipids; 1991 Dec; 26(12):1136-9. PubMed ID: 1819700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet-activating factor (PAF)-induced platelet aggregation by fatty acids from human saliva.
    Smal MA; Baldo BA
    Platelets; 2022 May; 33(4):562-569. PubMed ID: 34348059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C; Laurent L; Junier MP; Dray F
    J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Densitometric quantitation of platelet activating factor and other phospholipids in human saliva using enzyme reaction on a silica plate].
    Matsubara C; Ohyama T; Takamura K
    Yakugaku Zasshi; 1994 Sep; 114(9):681-90. PubMed ID: 7965653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple and precise method for the routine determination of platelet-activating factor in blood and urine.
    Demopoulos CA; Andrikopoulos NK; Antonopoulou S
    Lipids; 1994 Apr; 29(4):305-9. PubMed ID: 8177023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific, sensitive radioimmunoassay for platelet-activating factor (PAF).
    Smal MA; Baldo BA; McCaskill A
    J Immunol Methods; 1990 Apr; 128(2):183-8. PubMed ID: 2324511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and identification of hydroxyl-platelet-activating factor from natural sources.
    Tsoupras AB; Antonopoulou S; Baltas G; Samiotaki M; Panayotou G; Kotsifaki H; Mantzavinos Z; Demopoulos CA
    Life Sci; 2006 Oct; 79(19):1796-803. PubMed ID: 16860827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of PAF in blood by radioimmunoassay. Examination of interfering factors and problems involved in accurate quantification.
    Cooney SJ; Smal MA; Baldo BA
    J Immunol Methods; 1992 Jul; 151(1-2):131-8. PubMed ID: 1629604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor type activity in plasma from patients with septicemia and other diseases.
    Heuer HO; Darius H; Lohmann HF; Meyer J; Schierenberg M; Treese N
    Lipids; 1991 Dec; 26(12):1381-5. PubMed ID: 1819737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination for platelet-activating factor production by preimplantation mouse embryos using a specific radioimmunoassay.
    Smal MA; Dziadek M; Cooney SJ; Attard M; Baldo BA
    J Reprod Fertil; 1990 Nov; 90(2):419-25. PubMed ID: 2250241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques.
    Sugatani J; Lee DY; Hughes KT; Saito K
    Life Sci; 1990; 46(20):1443-50. PubMed ID: 2111868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a radioimmunoassay and bioassay for embryo-derived platelet-activating factor.
    Ammit AJ; O'Neill C
    Hum Reprod; 1991 Jul; 6(6):872-8. PubMed ID: 1757528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.